Creating vaccines for influenza clinical trials
Task V02: Manufacture of Influenza for Human Challenge Clinical Trials
This study is all about creating and testing new flu vaccines to make sure they're safe and effective for people, and it aims to help bring better options to those who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11127337 on NIH RePORTER |
What this research studies
This research focuses on the manufacturing and characterization of influenza vaccines for human challenge clinical trials. It involves developing and optimizing vaccine products, ensuring compliance with regulatory standards, and preparing them for clinical testing. The approach includes comprehensive planning, technical audits, and support for FDA submissions, aimed at facilitating the introduction of new vaccines and biologics to combat influenza. Patients may be involved in trials that assess the safety and efficacy of these vaccines.
Who could benefit from this research
Good fit: Ideal candidates for participation would include healthy adults who are willing to receive an influenza vaccine as part of a clinical trial.
Not a fit: Patients with severe allergies to vaccine components or those with compromised immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective influenza vaccines, improving prevention and treatment options for patients.
How similar studies have performed: Previous research has shown success in developing vaccines through similar manufacturing and clinical trial approaches.
Where this research is happening
New York, United States
- International AIDS Vaccine Initiative — New York, United States (Active)
Researchers
- Principal investigator: Hassel, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassel, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.